Singh Santosh Kumar, Singh Rajesh
Department of Microbiology, Biochemistry and Immunology, Cancer Health Equity Institute, Morehouse School of Medicine, Atlanta, GA, USA, 30310.
Cancer Health Disparities. 2020 Mar;4:e1-e10.
Liver cancer (LCa) is the fifth and eighth leading cause of cancer death for men and women, respectively. However, despite improvements in treatment strategies and options, it has limited therapeutic options. Worldwide, the prevalence of LCa varies widely. Various factors are associated with the development of LCa, and its incidence, morbidity, and mortality rates differ due to disparities that are multifactorial and complex, including genetic and geographic factors. The frequency of LCa varies by race/ethnicity, age and sex and relates to viral infections, lifestyle, nutrition, obesity, and health. In addition, various molecular factors, including cytokines, hormones, apoptosis, and mutations, are involved in disparities in the progression and mortality of LCa. Here, we provide an overall perspective on LCa by presenting available information on these associated factors and discussing their importance in its disproportionate incidences and clinical outcomes.
肝癌(LCa)分别是男性和女性癌症死亡的第五大及第八大主要原因。然而,尽管治疗策略和选择有所改进,其治疗选择仍然有限。在全球范围内,肝癌的患病率差异很大。多种因素与肝癌的发生发展相关,由于多因素和复杂的差异,包括遗传和地理因素,其发病率、发病率和死亡率各不相同。肝癌的发病率因种族/民族、年龄和性别而异,并且与病毒感染、生活方式、营养、肥胖和健康状况有关。此外,包括细胞因子、激素、细胞凋亡和突变在内的各种分子因素也与肝癌进展和死亡率的差异有关。在这里,我们通过介绍这些相关因素的现有信息并讨论它们在肝癌发病率和临床结果不均衡方面的重要性,提供了关于肝癌的整体观点。